Published in J Proteome Res on June 13, 2014
Isobaric labeling-based relative quantification in shotgun proteomics. J Proteome Res (2014) 1.09
Proteome-wide light/dark modulation of thiol oxidation in cyanobacteria revealed by quantitative site-specific redox proteomics. Mol Cell Proteomics (2014) 0.89
The Expanding Landscape of the Thiol Redox Proteome. Mol Cell Proteomics (2015) 0.84
Mass spectrometry-based detection and assignment of protein posttranslational modifications. ACS Chem Biol (2015) 0.84
Protein S-nitrosylation: specificity and identification strategies in plants. Front Chem (2015) 0.80
Mass spectrometry-based methods for identifying oxidized proteins in disease: advances and challenges. Biomolecules (2015) 0.79
Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res (2015) 0.78
In oesophageal squamous cells, nitric oxide causes S-nitrosylation of Akt and blocks SOX2 (sex determining region Y-box 2) expression. Gut (2015) 0.78
The Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle Function. Front Physiol (2015) 0.78
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification. Expert Rev Proteomics (2015) 0.77
Differential alkylation-based redox proteomics - Lessons learnt. Redox Biol (2015) 0.77
Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases. Proteomics Clin Appl (2016) 0.75
High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT. Analyst (2016) 0.75
Absolute quantitation of post-translational modifications. Front Chem (2014) 0.75
Loss of glyoxalase 1 induces compensatory mechanism to achieve dicarbonyl detoxification in mammalian Schwann cells. J Biol Chem (2016) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell (2009) 14.51
Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol (2005) 10.65
Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol (2001) 9.82
The generalisation of student's problems when several different population variances are involved. Biometrika (1947) 9.40
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol (2005) 7.25
An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol (2005) 5.93
Nitrosylation. the prototypic redox-based signaling mechanism. Cell (2001) 5.38
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol (2004) 5.15
S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science (2004) 4.97
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature (2006) 4.54
S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science (2009) 4.25
Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 3.92
Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med (2009) 3.75
(S)NO signals: translocation, regulation, and a consensus motif. Neuron (1997) 3.67
Novel neural modulators. Annu Rev Neurosci (2003) 2.91
SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci U S A (2006) 2.89
S-nitrosylation in health and disease. Trends Mol Med (2003) 2.85
Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol (2009) 2.69
Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci U S A (2006) 2.58
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A (2004) 2.55
Nitrosothiol reactivity profiling identifies S-nitrosylated proteins with unexpected stability. Chem Biol (2008) 1.94
Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood (2012) 1.89
Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc Natl Acad Sci U S A (2010) 1.87
Microglial activation in stroke: therapeutic targets. Neurotherapeutics (2010) 1.84
S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.73
Structural analysis of cysteine S-nitrosylation: a modified acid-based motif and the emerging role of trans-nitrosylation. J Mol Biol (2009) 1.62
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int Rev Neurobiol (2007) 1.59
The SNO-proteome: causation and classifications. Curr Opin Chem Biol (2010) 1.56
Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport (2002) 1.55
S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE (2001) 1.53
Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci Signal (2013) 1.45
Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J Neuroinflammation (2010) 1.41
Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. J Biol Chem (2008) 1.40
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics (2011) 1.40
MULTICOM: a multi-level combination approach to protein structure prediction and its assessments in CASP8. Bioinformatics (2010) 1.30
Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics (2010) 1.21
S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem (2009) 1.17
Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem Int (2001) 1.15
Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int (2005) 1.14
Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol (2010) 1.13
Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways. J Inflamm (Lond) (2011) 1.11
ERK is integral to the IFN-γ-mediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. J Immunol (2010) 1.11
The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev (2012) 1.07
Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia (2000) 1.07
14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol (2012) 1.05
S-nitrosylation of stargazin regulates surface expression of AMPA-glutamate neurotransmitter receptors. Proc Natl Acad Sci U S A (2009) 1.04
Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase. Brain Res (2007) 1.04
Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J (2013) 1.03
Detergent-free biotin switch combined with liquid chromatography/tandem mass spectrometry in the analysis of S-nitrosylated proteins. Rapid Commun Mass Spectrom (2008) 1.03
Detection of protein S-nitrosation using irreversible biotinylation procedures (IBP). Free Radic Biol Med (2010) 1.01
S-alkylating labeling strategy for site-specific identification of the s-nitrosoproteome. J Proteome Res (2010) 1.00
14-3-3 proteins in neurodegeneration. Semin Cell Dev Biol (2011) 0.99
Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin. FEBS Lett (2013) 0.95
Quantification of protein isoforms in mesenchymal stem cells by reductive dimethylation of lysines in intact proteins. Proteomics (2012) 0.92
Re-evaluation of amino acid sequence and structural consensus rules for cysteine-nitric oxide reactivity. Biol Chem (2000) 0.92
Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia. Antioxid Redox Signal (2013) 0.90
Protein microarray characterization of the S-nitrosoproteome. Mol Cell Proteomics (2013) 0.89
Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med (2001) 0.89
Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol (2004) 0.88
Transcriptional regulation of iNOS and COX-2 by a novel compound from Curcuma comosa in lipopolysaccharide-induced microglial activation. Neurosci Lett (2009) 0.81
Genome sequence of the palaeopolyploid soybean. Nature (2010) 17.82
A large-scale evaluation of computational protein function prediction. Nat Methods (2013) 4.61
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature (2006) 4.54
Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J (2006) 4.43
S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science (2009) 4.25
S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science (2002) 4.13
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature (2002) 3.20
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A (2004) 2.55
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci (2005) 2.54
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Medical student attitudes toward the doctor-patient relationship. Med Educ (2002) 2.10
Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem (2012) 1.96
Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res (2002) 1.95
Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem (2007) 1.91
Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem (2007) 1.90
Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol (2002) 1.87
Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res (2006) 1.78
Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci (2005) 1.75
S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.73
Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol (2005) 1.71
Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res (2010) 1.69
Evaluating the absolute quality of a single protein model using structural features and support vector machines. Proteins (2009) 1.63
Genistein alters methylation patterns in mice. J Nutr (2002) 1.60
Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am J Physiol Heart Circ Physiol (2006) 1.59
Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J Comp Neurol (2002) 1.57
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology (2007) 1.53
Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res (2008) 1.49
Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol Cell (2010) 1.44
The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology (2003) 1.43
NNcon: improved protein contact map prediction using 2D-recursive neural networks. Nucleic Acids Res (2009) 1.43
Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci (2005) 1.43
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain (2008) 1.42
Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol (2003) 1.40
SoyDB: a knowledge database of soybean transcription factors. BMC Plant Biol (2010) 1.40
Assessment of predictions submitted for the CASP7 domain prediction category. Proteins (2007) 1.39
Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res (2005) 1.38
Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A (2002) 1.35
The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med (2002) 1.32
A role for caleosin in degradation of oil-body storage lipid during seed germination. Plant J (2006) 1.31
MULTICOM: a multi-level combination approach to protein structure prediction and its assessments in CASP8. Bioinformatics (2010) 1.30
Soybean Knowledge Base (SoyKB): a web resource for soybean translational genomics. BMC Genomics (2012) 1.29
Predicting protein residue-residue contacts using deep networks and boosting. Bioinformatics (2012) 1.28
APOLLO: a quality assessment service for single and multiple protein models. Bioinformatics (2011) 1.26
Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif. Neuron (2007) 1.26
Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem (2008) 1.25
Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab (2007) 1.23
Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol (2010) 1.23
Neuroprotection by the NR3A subunit of the NMDA receptor. J Neurosci (2009) 1.22
Root hair systems biology. Trends Plant Sci (2010) 1.21
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J Neuroinflammation (2006) 1.20
Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol (2003) 1.20
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol (2012) 1.19
Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology (2003) 1.17
Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA₂-IIA expression in astrocytes and microglia. J Neuroinflammation (2011) 1.16
Large-scale reconstruction of 3D structures of human chromosomes from chromosomal contact data. Nucleic Acids Res (2014) 1.16
PreDisorder: ab initio sequence-based prediction of protein disordered regions. BMC Bioinformatics (2009) 1.15
Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int (2005) 1.14
Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci (2005) 1.13
Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci (2006) 1.13
Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab (2008) 1.12
3Drefine: consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization. Proteins (2012) 1.12
Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol Neurobiol (2005) 1.11
Botanical phenolics and brain health. Neuromolecular Med (2008) 1.11
A comprehensive overview of computational protein disorder prediction methods. Mol Biosyst (2011) 1.10
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener (2012) 1.10
DNdisorder: predicting protein disorder using boosting and deep networks. BMC Bioinformatics (2013) 1.09
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J Proteome Res (2010) 1.09
The polycystic kidney disease-related proteins Bicc1 and SamCystin interact. Biochem Biophys Res Commun (2009) 1.09
DoBo: Protein domain boundary prediction by integrating evolutionary signals and machine learning. BMC Bioinformatics (2011) 1.08
Localization of vacuolar transport receptors and cargo proteins in the Golgi apparatus of developing Arabidopsis embryos. Traffic (2007) 1.08
Selective membrane protein internalization accompanies movement from the endoplasmic reticulum to the protein storage vacuole pathway in Arabidopsis. Plant Cell (2005) 1.08
Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem (2004) 1.07
TMBpro: secondary structure, beta-contact and tertiary structure prediction of transmembrane beta-barrel proteins. Bioinformatics (2007) 1.07
Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells. J Neurosci (2008) 1.06
Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med (2007) 1.06
Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener (2011) 1.05
Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase. Brain Res (2007) 1.04
Ty3 capsid mutations reveal early and late functions of the amino-terminal domain. J Virol (2007) 1.03
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Ideals, activities, dissonance, and processing: a conceptual model to guide educators' efforts to stimulate student reflection. Acad Med (2010) 1.03
A unique family of proteins associated with internalized membranes in protein storage vacuoles of the Brassicaceae. Plant J (2005) 1.03
Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer (2004) 1.03
P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem (2003) 1.02
Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem (2002) 1.02
Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res (2004) 1.02
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Carcinogenesis (2009) 1.02
The properties of genome conformation and spatial gene interaction and regulation networks of normal and malignant human cell types. PLoS One (2013) 1.01
Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Mol Neurobiol (2012) 1.01
Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J Neurochem (2010) 1.01
Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res (2002) 1.00
Male-specific lethal complex in Drosophila counteracts histone acetylation and does not mediate dosage compensation. Proc Natl Acad Sci U S A (2013) 1.00
Protein disorder prediction at multiple levels of sensitivity and specificity. BMC Genomics (2008) 0.99
Alpha tonoplast intrinsic protein is specifically associated with vacuole membrane involved in an autophagic process. Plant Cell Physiol (2003) 0.98